Surface-Engineered Phytochemical Nanomedicines for Postmenopausal Osteoporosis: Skeletal Targeting, Imaging-Supported Evaluation, and Therapeutic Performance
Rattachement africain : cn. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Postmenopausal osteoporosis (PMOP) is a metabolic bone disease driven by estrogen deficiency and a major contributor to fragility fractures, yet long-term use of current antiresorptive and anabolic agents remains constrained by tolerability and adherence. Plant-derived bioactive compounds—including flavonoids, isoflavones, curcuminoids, and stilbenes—show bone-protective activity in ovariectomized (OVX) models but share common delivery barriers: poor aqueous solubility, low oral bioavailability, rapid metabolic clearance, and limited skeletal targeting. Conventional nanonization improves systemic pharmacokinetics but cannot by itself address the spatial heterogeneity of skeletal target sites. This review focuses on surface-engineered phytochemical nanomedicines, in which mineral-affinity, cell-affinity, and pathology-responsive modules are introduced at the carrier interface to enhance bone-associated distribution, local retention, and microenvironment-responsive release. Organized around nanocarrier platforms, it summarizes cross-platform surface/interfacial engineering strategies and discusses how whole-body, ex vivo, and bone-section imaging can be combined with quantitative exposure assessment, micro-computed tomography (micro-CT), bone turnover markers, and histology to characterize carrier- or probe-associated distribution, spatial localization, and therapeutic performance, respectively. It then considers translational issues, including formulation reproducibility, ligand-density effects, model relevance, and long-term safety. The review aims to provide a framework for surface-engineered phytochemical strategies and a reference approach for multimodal, imaging-based evaluation of therapeutic outcomes.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Surface-Engineered Phytochemical Nanomedicines for Postmenopausal Osteoporosis: Skeletal Targeting, Imaging-Supported Evaluation, and Therapeutic Performance
- Date Crossref
- 16/09/2026
- Éditeur
- MDPI AG
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
Hebei Medical University Department of Spinal Surgery pays non établi dans la noticeUniversité ou école supérieure
-
Third Hospital of Hebei Medical University pays non établi dans la noticeÉtablissement de santé
Department of Spinal Surgery — Hebei Medical University et Third Hospital of Hebei Medical University.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.